A Study to Evaluate the Effect of Clarithromycin on LY2216684

Summary

The study will evaluate the effect of Clarithromycin on the pharmacokinetics (PK) of LY2216684 in healthy participants. Side effects will be documented. There will be 2 study periods (5 and 9 days) and follow up will occur at least 7 days after the last dose. Screening is required within 45 days prior to the start of the study.

Timeline

Start

2011-10

Primary completion

2011-12

Completion

2011-12

Drugs

Indications